What does 10x Genomics, Inc. (TXG) do?

10x Genomics, Inc. (TXG) is a publicly traded company in the Industrials sector.

What sector does TXG operate in?

10x Genomics, Inc. operates in the Industrials, specifically within the Laboratory Analytical Instruments industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find TXG earnings analysis?

AlphaOS publishes an earnings intelligence page for 10x Genomics, Inc. (TXG) covering results, guidance context, and AI-assisted analysis. See /stocks/TXG/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

TXG

10x Genomics, Inc.

Industrials · Laboratory Analytical Instruments

$90.04Sep 29, 2026

AI confidence 62% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

10x Genomics, Inc. shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -13% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -13% YoY in Q2 FY2026

Pipeline evidence · 0d ago

TXG's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on TXG.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full TXG earnings analysis

Reported figures for 10x Genomics, Inc. — research only, not investment advice.

Revenue YoY: -12.6%
EPS YoY: -150.0%

Latest Intelligence

Updated September 29, 2026

What happened recently for 10x Genomics, Inc. (TXG) — events, not interpretation.

Event: Reported Q2 2026 revenue -13% YoY.
Also: Last session September 29, 2026 at $90.04.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

10x Genomics, Inc. (TXG)

Industrials · Laboratory Analytical Instruments

Investment Snapshot above is the primary AlphaOS analysis for 10x Genomics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Industrials
Industry:: Laboratory Analytical Instruments
Market cap:: $11.62B
Revenue:: $151.04M

TXG earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow 10x Genomics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related & Connected

Sotera Health Co80% confidencerelated

Connected companies and research pages from the AlphaOS knowledge graph.

TXG